Program Description
Metabolic dysfunction-associated steatohepatitis (MASH) is a severe,
inflammatory form of liver disease associated with various metabolic
comorbidities, such as type 2 diabetes and obesity. A growing understanding of
disease pathogenesis has contributed to the emergence and recent therapy
approvals, including THR-β agonists and GLP-1 receptor agonists, that target
fibrotic and metabolic pathways. As the prevalence of MASH continues to rise
alongside an evolving treatment landscape, pharmacists are positioned to
provide and optimize comprehensive care for patients with MASH. This activity
will discuss disease-modifying intervention strategies to reduce the clinical
burden associated with MASH, emphasizing the early identification and management
of underlying cardiometabolic risk factors. Challenges navigating access to
MASH therapies, key patient counseling considerations related to lifestyle
modifications and medication use, and approaches to coordinating safe
multidisciplinary care will be addressed to support improved patient outcomes. This symposium is the third in the MASLD/MASH curriculum
Target audience: Specialty
and health-system pharmacists
Type of activity: Application
Release date: May 31, 2026
Expiration date: May 31, 2027
Learner level: Foundational
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the role of the pharmacist in improving care and outcomes for patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
- Identify common barriers to care in MASH, including insurance coverage and access challenges, to ensure timely initiation of approved and emerging therapies
- Construct a multidisciplinary monitoring plan that tracks treatment response, safety, and long-term cardiometabolic risk reduction for patients receiving MASH pharmacotherapy
Sandy Sallam, PharmD, BCACP, CDCES
Clinical Pharmacist
Stanford Health Care
Redwood City, CA
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-26-166-H01-P. The activity is available for CE credit through May 31, 2027.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with ineligible companies to disclose:
Faculty
Sandy Sallam, PharmD, BCACP, CDCES
Clinical Pharmacist
Stanford Health Care
Redwood City, CA
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Rose Buszka, PharmD, BCPS, CHCP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta
Any relevant financial relationships listed for these individuals have been mitigated.
At least one anonymous peer reviewer was used as part of content
validation and conflict resolution. The peer reviewer has no relevant financial
relationships with ineligible companies to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms